Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Pediatric Drugs Market Size Changed, over the years?
Recent years have seen the pediatric drugs market expand swiftly. Its size is projected to increase from $157.0 billion in 2024, to $181.02 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.3%. The considerable growth in the previous timeline can be linked to the increasing demand for corresponding medicines, a higher pediatric populace, better knowledge and recognition of pediatric ailments, the development of pediatric oncology, the advent of digital health and telemedicine, and intensified collaboration in the formulation of pediatric drugs.
How Much Will the Pediatric Drugs Market Be Worth in 2029?
The market for pediatric drugs is predicted to experience significant expansion in the upcoming years, expecting to reach $316.0 billion in 2029, with a compound annual growth rate (CAGR) of 14.9%. This surge during the forecast period can be attributed to several factors, such as an increase in the pediatric population, a surge in pediatric mental health disorders, a rise in chronic conditions among children, elevated vaccination rates among children, and an increased demand for pediatric mental health medications. Key trends anticipated in the forecast period include individualized pediatric medications, the integration of technology in pediatric drug delivery, the use of telemedicine and digital health solutions, improvements in pediatric clinical trials, and the collaboration of pediatricians and pharmacists.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21249&type=smp
Which is the Largest Company in the Pediatric Drugs Market?
Major companies operating in the pediatric drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb, AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Co., Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Vertex Pharmaceuticals, UCB Pharma, Sun Pharmaceutical Industries Ltd., Perrigo Company, Shionogi & Co. Ltd., Mallinckrodt, Torrent Pharmaceuticals Ltd, Sarepta Therapeutics, Zydus Cadila
What Are the Main Market Drivers in the Pediatric Drugs Industry?
An increase in preterm births, babies born prior to the 37th week of gestation rather than the standard 40 weeks, is anticipated to boost the expansion of the pediatric drugs market. This surge in early deliveries is related to a multitude of factors including advanced maternal age, lifestyle factors, pre-existing health conditions, multiple gestations, and insufficient prenatal care. Pediatric drugs play a crucial role in fostering the health and growth of premature infants, by providing specialized treatments for issues such as respiratory complications, infections, and nutritional deficiencies. As per a report released by Tommy’s, a charity organization from the UK, in December 2022, there was an increase in the rate of premature live births in England and Wales from 7.5% in 2021 to 7.9% in 2022, equating to over 53,000 premature births in 2022. Subsequently, this upswing in preterm births is sparking the development of the pediatric drugs market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21249&type=smp
How Is the Pediatric Drugs Market Segments Structured?
The pediatric drugs market covered in this report is segmented –
1) By Type: Respiratory Disorder Drugs, Autoimmune Disorder Drugs, Gastrointestinal Drugs, Cardiovascular Drugs
2) By Route Of Administration: Oral, Topical, Parenteral, Other Route Of Administrations
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
4) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Respiratory Disorder Drugs: Asthma Medications, Cystic Fibrosis Treatments, Bronchodilators, Corticosteroids
2) By Autoimmune Disorder Drugs: Immunosuppressants, Biologic Therapies, Disease-Modifying Antirheumatic Drugs (DMARDs)
3) By Gastrointestinal Drugs: Proton Pump Inhibitors (PPIs), Antiemetics, Antidiarrheals, Laxatives
4) By Cardiovascular Drugs: Antihypertensive Medications, Heart Failure Treatments, Antiarrhythmic Drugs, Lipid-lowering Agents
What Strategic Trends Are Transforming the Pediatric Drugs Market?
Leading pediatric drug market firms are concentrating on creating innovative medicines, like fully human monoclonal antibodies, to enhance treatment results and limit side effects in young patients. A fully human monoclonal antibody (mAb) is entirely formed from human genetic sequences, thus reducing the likelihood of immune system responses compared to chimeric or humanized monoclonal antibodies. These antibodies are created using sophisticated biotech methods, such as transgenic mice carrying human antibody genes or phage display technology. For example, in August 2022, Johnson and Johnson, an American pharmaceutical firm, obtained FDA approval for STELARA (ustekinumab) to treat pediatric patients six years and older suffering active PsA. This approval is a milestone since STELARA is the first and only biologic therapy that targets interleukin-12 (IL-12) and interleukin-23 (IL-23), which are crucial cytokines involved in the inflammatory responses connected with autoimmune diseases. Active PsA is an uncommon condition influencing about 5-8% of kids with chronic inflammatory arthritis, causing symptoms like joint swelling and skin lesions.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/pediatric-drugs-global-market-report
Which Global Regions Offer the Highest Growth in the Pediatric Drugs Market?
North America was the largest region in the pediatric drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pediatric drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21249
This Report Delivers Insight On:
1. How big is the pediatric drugs market, and how is it changing globally?
2. Who are the major companies in the pediatric drugs market, and how are they performing?
3. What are the key opportunities and risks in the pediatric drugs market right now?
4. Which products or customer segments are growing the most in the pediatric drugs market?
5. What factors are helping or slowing down the growth of the pediatric drugs market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model